Novelrad
Minimally-invasive Suturing for Vascular and Heart Defect Closure
StartupNovelrad is a Metzer-based startup in the Health Tech & Life Sciences sector, established in 2019. Minimally-invasive Suturing for Vascular and Heart Defect Closure. Novelrad was founded by Netanel Sharabani and Ori Goldor. The company has 1-10 employees.
The company follows a B2B business model. Product stage: Released.
- StagePre-Funding
- ProductReleased
- ModelB2B
- Employees1-10
- HQMetzer
- Last RoundUndisclosed
Netanel SharabaniCo-founder & CEO
Ori GoldorCo-founder & R&D Manager
1 article covered by sources including rasph.com.
What does Novelrad do?
Novelrad has developed a micro sewing machine that can deploy a range of continuous suture patterns, percutaneously, with a simple click of a button. The versatile suturing platform mimics the surgical ‘gold standard’ and can address multiple indications in the cardiovascular system and beyond. The device deploys a multipoint purse string suture at the beginning of the procedure, thereby, enabling safe dilation and reliable closure at the end of the procedure. The Novelrad VCD features an unprecedented range of bore sizes using a single device.
Who founded Novelrad?
Novelrad was founded in 2019 by Netanel Sharabani (Co-founder & CEO), Ori Goldor (Co-founder & R&D Manager).
What sector is Novelrad in?
Novelrad operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is Novelrad located?
Novelrad is based in Metzer, Israel.